HPR100 Analysis of the Drug Price Level of Anticancer and Rare Disease Drugs After the Implementation of Economic Evaluation Exemption in South Korea
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1230
https://www.valueinhealthjournal.com/article/S1098-3015(22)03435-0/fulltext
Title :
HPR100 Analysis of the Drug Price Level of Anticancer and Rare Disease Drugs After the Implementation of Economic Evaluation Exemption in South Korea
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03435-0&doi=10.1016/j.jval.2022.09.1230
First page :
Section Title :
Open access? :
No
Section Order :
10778